Do race, ethnicity, and psychiatric diagnoses matter in the prevalence of multiple chronic medical conditions?

Medical Care

Volumn 51, Issue 6, 2013, Pages 540-547

  Cabassa, Leopoldo J ^a,b   Humensky, Jennifer ^b   Druss, Benjamin ^c   Lewis Fernández, Roberto ^a,b   Gomes, Arminda P ^a   Wang, Shuai ^b   Blanco, Carlos ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Health disparities; Health services research; Mental disorders; Multiple chronic medical conditions; National Epidemiologic Survey on Alcohol and Related Condition

Indexed keywords

ADULT; ARTICLE; BODY MASS; CHRONIC DISEASE; DEMOGRAPHY; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTIPLE CHRONIC MEDICAL CONDITION; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; QUALITY OF LIFE; RACE; RISK ASSESSMENT; SOCIAL STATUS;

ADULT; AFRICAN AMERICANS; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SURVEYS; HISPANIC AMERICANS; HUMANS; LOGISTIC MODELS; MALE; MENTAL DISORDERS; MIDDLE AGED; PREVALENCE; UNITED STATES;

EID: 84879093717     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0b013e31828dbb19     Document Type: Article

References (48)

1. US Department of Health and Human Services. Mutiple Chronic Conditions: A Strategic Framework: Optimum Health and Quality of Life for Individuals with Multiple Chornic Conditions. Washington, DC: U. S. Department of Health and Human Services; 2010.
2. Anderson G. Chronic Care: Making the Case for Ongoing Care. Princeton: Robert Wood Johnson Foudnation; 2010.
3. Vogeli C, Shields AE, Lee TA, et al. Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs. J Gen Intern Med. 2007;22(Suppl 3):391-395.
4. Parekh AK, Barton MB. The challenge of multiple comorbidity for the US health care system. JAMA. 2010;303:1303-1304.
5. Pleais JR, Lucas JW, Ward BW. Summary Health Statistics for US Adults: National Health Interview Survery, 2008. Washington, DC: National Center for Health Statistics; 2009.
6. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta, GA: U. S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011.
7. Gold DR, Wright R. Population disparities in asthma. Annu Rev Public Health. 2005;26:89-113.
8. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2003.
9. Grigsby AB, Anderson RJ, Freedland KE, et al. Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res. 2002;53:1053-1060.
10. Musselman DL, Betan E, Larsen H, et al. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry. 2003;54:317-329.
11. Goodwin RD, Davidson KW, Keyes K. Mental disorders and cardiovascular disease among adults in the United States. J Psychiatr Res. 2009;43:239-246.
12. Newcomer JW, Hennekens CH. Severe mental illness and risk of cardiovascular disease. JAMA. 2007;298:1794-1796.
13. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64:1123-1131.
14. Druss BG, Walker ER. Mental Disorders and Medical Comorbidity. The Synthesis Project Research Synthesis Report No 21. Princeton, NJ: Robert Wood Johnson Foundation; 2011.
15. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160:3278-3285.
16. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54:216-226.
17. Stecker T, Fortney JC, Steffick DE, et al. The triple threat for chronic disease: obesity, race, and depression. Psychosomatics. 2006;47:513-518.
18. Henderson DC, Nguyen DD, Copeland PM, et al. Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study. J Clin Psychiatry. 2005;66:1116-1121.
19. Dixon L, Weiden P, Delahanty J, et al. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull. 2000;26:903-912.
20. Adler NE, Newman K. Socioeconomic disparities in health: pathways and policies. Health Aff. 2002;21:60-76.
21. Institute of Medicine. Improving Quality of Health Care for Mental and Substance use Conditions: Quality Chasm Series. Washington, DC: National Academies Press; 2006.
22. Grant BF, Dawson DA, Hasin DS. The Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSMIV Version. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2004.
23. Grant BF, Compton WM, Crowley TJ, et al. Errors in assessing DSM-IV substance use disorders. Arch Gen Psychiatry. 2007;64:379-380.
24. Grant B, Kaplan K, Moore T, et al. 2004-2005 Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions: Source and Accuracy Statement. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2007.
25. Grant BF, Goldstein RB, Chou SP, et al. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry. 2008;14:1051-1066.
26. Grant BF, Hasin DS, Blanco C, et al. The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005;66:1351-1361.
27. Ruan WJ, Goldstein RB, Chou SP, et al. The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug Alcohol Depend. 2008;92:27-36.
28. Canino G, Bravo M, Ramirez R, et al. The Spanish Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population. J Stud Alcohol. 1999;60:790-799.
29. Hasin D, Carpenter KM, McCloud S, et al. The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend. 1997;44:133-141.
30. Cabassa LJ, Blanco C, Lopez-Castroman J, et al. Racial and ethnic differences in diabetes among individuals with psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Gen Hosp Psychiatry. 2011;33:107-115.
31. Compton WM, Thomas YF, Stinson FS, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007;64:566-576.
32. Schneider KM, O'Donnell BE, Dean D. Prevalence of multiple chronic conditions in the United States' Medicare population. Health Qual Life Outcomes. 2009;7:82.
33. Agborsangaya CB, Lau D, Lahtinen M, et al. Multimorbidity prevalence and patterns across socioeconomic determinants: a cross-sectional survey. BMC Public Health. 2012;12:201.
34. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-233.
35. Research Triangle Institute. Software for Survey Data Analysis (SUDAAN) Version 9.0. Research Triangle Park, NC: Research Triangle Institute; 2004.
36. Cossrow N, Falkner B. Race/ethnic issues in obesity and obesity-related comorbidities. J Clin Endocrinol Metab. 2004;89:2590-2594.
37. Kurian AK, Cardarelli KM. Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. Ethn Dis. 2007;17:143-152.
38. Chapman DP, Perry GS, Strine TW. The vital link between chronic disease and depressive disorders. Prev Chronic Dis. 2005;2:A14.
39. Druss BG, Zhao L, Cummings JR, et al. Mental comorbidity and quality of diabetes care under Medicaid: a 50-state analysis. Med Care. 2012;50:428-433.
40. Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, reseach and medical education: a cross-sectional study. The Lancet. 2012;380:37-43.
41. Alakeson V, Frank RG, Katz RE. Specialty care medical homes for people with severe, persistent mental disorders. Health Aff. 2010;29:867-873.
42. Cabassa LJ, Ezell JM, Lewis-Fernández R. Lifestyle intervention for adults with serious mental illness: a systematic literature review. Psychiatr Serv. 2010;61:774-782.
43. Druss BG, Von Esenwein SA, Compton MT, et al. A randomized trial of medical care management for community mental health settings: the Primary Care Access, Referral, and Evaluation (PCARE) study. Am J Psychiatry. 2010;167:151-159.
44. Druss BG, Zhao L, Von Esenwein SA, et al. The Health and Recovery Peer (HARP) Program: a peer-led intervention to improve medical self-management for persons with serious mental illness. Schizophr Res. 2010;118:264-270.
45. Kilbourne AM, Post EP, Nossek A, et al. Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial. Psychiatr Serv. 2008;59:760-768.
46. McKibbin CL, Patterson TL, Norman G, et al. A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res. 2006;86:36-44.
47. Farley T, Cohen DA. Prescription for a Healthy Nation: A New Approach to Improving Our Lives by Fixing Our Everyday World. Boston: Beacon Press; 2005.
48. Horrigan key. Health care reform bill contains opportunities for integrative medicine. Explore (NY). 2010;6:221-224.